title: Lifitegrast (Xiidra) for dry eye disease.
mesh_terms: D060433:Administration, Ophthalmic; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D015352:Dry Eye Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology; D009883:Ophthalmic Solutions; D010649:Phenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D016169:Lymphocyte Function-Associated Antigen-1; D009883:Ophthalmic Solutions; D013450:Sulfones; C575157:lifitegrast; D010649:Phenylalanine